Biologics CDMO Market Trends and Investment Forecast to 2033: Features Analysis of Lonza Group, Catalent Pharma Solutions, Samsung Biologics and Other Key Industry Players - ResearchAndMarkets.com

DUBLIN--( BUSINESS WIRE)--The "Biologics Contract Development and Manufacturing Organization Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering.

The global biologics contract development and manufacturing organization (CDMO) market, valued at USD 19.22 billion in 2024, is projected to grow at a compound annual growth rate of 9.21%, reaching USD 42.32 billion by 2033. This expansion is fueled by the increasing demand for targeted therapies to address chronic and rare diseases within an aging global population.

Pharmaceutical and biopharmaceutical companies are leveraging CDMO services to enhance their capacities and access specialized technologies. This trend is further supported by rising investments and a surge in venture capital, strategic collaborations, mergers, and acquisitions across the industry. Major pharmaceutical corporations are focusing on acquisitions to diversify their therapeutic portfolios and bolster biologics pipelines.

The shifting focus of regulatory bodies such as the U.S. FDA and EMA on refining approval pathways for biosimilars, cell therapies, and gene-based treatments is fostering innovation while ensuring patient safety. New harmonized standards are streamlining submissions, reducing delays, and driving market expansion through faster approvals of novel therapies.

Global Biologics CDMO Market Segmentation

This report delivers revenue growth forecasts at global, regional, and country levels from 2021 to 2033 across several sub-segments, divided by product, service, source, workflow, therapeutic area, and region.

Product Outlook (Revenue, USD Million, 2021-2033)

Service Outlook (Revenue, USD Million, 2021-2033)

Source Outlook (Revenue, USD Million, 2021-2033)

Workflow Outlook (Revenue, USD Million, 2021-2033)

Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)

End Use Outlook (Revenue, USD Million, 2021-2033)

Regional Outlook (Revenue, USD Million, 2021-2033)

Why You Should Buy This Report

Report Deliverables

Key Attributes

The companies profiled in this Biologics Contract Development and Manufacturing Organization market report include:

For more information about this report visit https://www.researchandmarkets.com/r/idjtme

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.